Balance Sheet Data

Bristol-Myers Squibb Company (BMY)

$50.75

-0.17 (-0.33%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 12,34614,54613,9799,12312,28016,731.0119,605.9722,974.9426,922.8231,549.08
Total Cash (%)
Account Receivables 7,6858,50112,51613,93715,26414,817.6517,363.8320,347.5323,843.9327,941.14
Account Receivables (%)
Inventories 4,2932,0742,0952,3392,6623,881.264,548.195,329.736,245.567,318.76
Inventories (%)
Accounts Payable 2,4452,7132,9493,0403,2593,788.534,439.535,202.406,096.357,143.91
Accounts Payable (%)
Capital Expenditure -836-753-973-1,118-1,209-1,284.17-1,504.83-1,763.41-2,066.43-2,421.51
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.